期刊
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
卷 9, 期 12, 页码 4239-4242出版社
ELSEVIER
DOI: 10.1016/j.jaip.2021.07.034
关键词
Adherence; Asthma; Compliance; Chronic obstructive pulmonary disease; Shared decision-making
Adherence to prescribed medications for chronic respiratory disease is crucial for successful management, but there is little consensus on how to measure adherence, optimal adherence, and goals of appropriate medication utilization. Criteria may vary when studying medication utilization at the patient or population level. Consistent medication use in chronic respiratory disease is associated with better outcomes, and shared decision-making is one strategy to achieve appropriate levels of adherence, requiring negotiation and compromise by both patient and provider.
Adherence to prescribed medications for chronic respiratory disease is considered a keystone for successful management. There is little consensus, though, on how to measure adherence, what is optimal adherence, or the goals of appropriate medication utilization These criteria may differ when studying medication utilization at the patient or population level. The role of consistent medication use in chronic respiratory disease is associated with better outcomes. Shared decision-making is one strategy to achieve appropriate levels of adherence that requires negotiation, compromise by both patient and provider. It also recognizes that both success and failure to achieve goals of adherence are shared. As such, we discuss the current understanding of adherence measures in respiratory disease and identify the need for more nuanced approaches to evaluate adherence to reach acceptable patient outcomes. (C) 2021 American Academy of Allergy, Asthma & Immunology
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据